Netflix has hundreds of movie and TV show options that appeal to mature sensibilities, but when you're in the mood for something milder or need a consensus choice for family movie night, the streamer ...

From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to treat blindness and the visually impaired.

SpaceX’s reported acquisition of xAI marks a pivotal moment for the next wave of industrial robotics innovation. While SpaceX is ...

Scientists reverse eye cell aging with ER-100 gene therapy that reprograms retinal neurons to younger states, offering hope for glaucoma and vision loss.

BOSTON, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, ...

Microsoft has unveiled Rho-alpha, a next-generation robotics AI model designed to help machines understand the physical world, make decisions in ...

Visual Studio 2026 includes GitHub Copilot functionality built into the IDE, while third-party AI coding assistants remain available through the Visual Studio Marketplace. Using Marketplace install ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...

“For the hashtag explorer, we wanted to let readers dig into their own TikTok niche. The ‘opposite’ hashtags, or ones that are most negatively correlated with your selected one, are also a fun way to ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Shaun Nolan does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...